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Abstract
Periodontitis is a chronic inflammatory disease affecting the supporting structures of the
teeth and results in loss of supporting bone around the teeth leading to eventual tooth
loss. It is a multifactorial disease that involves bacteria and host responses. Advanced
options to treat periodontitis are aimed at regeneration procedures to restore lost peri-
odontal structures. These include bone replacement grafts and the use of biological mate-
rials to enhance regeneration. Platelet-rich fibrin (PRF) is an autologous platelet-rich
concentrate derived from a fibrin clot and is a natural source of growth factors derived
from platelets, which are released over time and have been shown to have potential in
periodontal procedures to enhance wound healing and regeneration. This chapter will
focus on the past, current and future scope of PRF for treating periodontitis.
Keywords: platelet-rich fibrin, periodontitis, autologous, growth factors, regeneration,
healing
1. Introduction
Blood is an integral part of the human body, which is responsible in delivering necessary
nutrients and oxygen to different cells and also transports the metabolic waste products from
those cells to be excreted out of the body. Blood includes four components: platelets, white
blood cells (WBCs), red blood cells (RBCs) and plasma. Particularly, platelets play a major role
in the release of growth factors at the site of injury to initiate wound healing [1]. Wound
healing is an essential inflammatory process which requires cellular organization and remod-
eling, cellular migration and cellular proliferation. Platelets play a crucial role in all of these
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functions. Due to these properties, the concept of using platelet concentrates for therapeutic
purposes was introduced. The main aim was to isolate large numbers of platelets from the
whole blood and then use them to enhance the wound healing process. Initially, platelet-rich
plasma (PRP) was developed for this purpose and can be considered as the first generation of
the platelet concentrates. Whole blood was collected and anticoagulants (i.e., calcium chloride
or bovine thrombin) were added to the blood prior to centrifugation to prevent clotting. The
platelet-rich fraction was removed after the blood components were separated by centrifuga-
tion. Various studies showed that the final product after processing contained 95% platelets
and played direct roles in influencing osteoblasts, periodontal ligament cells, connective tissue
cells and epithelial cells [2]. Due to the lengthy centrifugation protocols, the need for special-
ized equipment, and the need to combine the liquid PRP with other biomaterials made it
cumbersome to use in a clinical setting for outpatient oral and maxillofacial surgeries and
periodontal surgical procedures. To overcome the limitations presented by PRP, the second
generation of platelet concentrates (i.e., platelet-rich fibrin, PRF) was developed [3].
With the main objective of obtaining platelet concentrates without the addition of the anticoagu-
lation agents, a new protocol was developedwhich included centrifuging the blood at high speed
(3000 rpm) for 10 minutes to separate different components that included the heavier RBCs in the
bottom of the centrifugation tube, clear serum at the top of the tube with an interposed fibrin clot
layer consisting largely of platelets and WBCs [3, 4]. Because no anti-coagulation factors were
used, a three-dimensional yellow fibrin clot was obtained between the two liquid layers and was
termed as PRF (Figure 1). It was shown that approximately 97% of the platelets and >50% of the
leucocytes in the blood sample were concentrated in the PRF clot and due to its additional
Figure 1. PRF clot after centrifugation.
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leucocyte content, these platelet concentrates are also sometimes referred to as leucocyte-PRF
(L-PRF) [4].
1.1. PRF processing
Intravenous blood is collected through venipuncture (superficial veins in arm: median cubital
vein, cephalic vein, basilica vein or dorsal metacarpal veins) and collected in 10-ml sterile tubes
without anticoagulants (Figure 2a). The volume of blood depends upon the application of the
PRF. Immediately after collection of the venous blood, the tubes are centrifuged at specified
speed and time as shown in Figure 2b. This centrifugation allows the formation of the fibrin-
scaffold in the middle of the tube as shown in Figures 1 and 2c. This fibrin clot is separated
from the red corpuscles base with the help of the sterile tweezers and scissors and is trans-
ferred to the sterile PRF box for compression (Figure 2d). The minimum compression period
required is 4–5 minutes for uniform thickness. This converts the clot into PRF membrane
(Figure 2e) which can be used for various applications in the field of periodontics as discussed
later. The lower chamber of the box collects the exudate after the compression which may be
used for hydration of other regenerative materials (Figure 2f).
Figure 2. (a–f) PRF procedure. (a) Blood collection, (b) centrifugation, (c and d) fibrin clot, (e) PRF membrane after
compression, (f) Exudate collected in lower chamber.
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1.2. Properties of PRF
With the advancement and research to explore the properties of the PRF, various procedures
have been established for the formulation of the PRF [5]. Studies have been carried out to
evaluate the significance of different protocols which are based on different centrifugation
speeds and times [5, 6]. The L-PRF procedure includes centrifugation at 2700 rpm for
12 minutes was the first well-documented procedure. It was followed by an advanced-PRF
(A-PRF) procedure, which includes centrifugation at 1500 rpm for 14 minutes [5–7]. The
differences in the properties due to different procedures will be discussed based on the
available evidence. All three concentrates of platelets (PRP, L-PRF, and A-PRF) have been
shown to release growth factors when processed as described above but each differs in its
growth factor release kinetics [6]. PRFs, the most commonly studied platelet concentrate, have
been shown to contain growth factors that are produced by and released from platelets
including: platelet-derived growth factors (PDGFs), transforming growth factor β1 (TGF-β1),
vascular endothelial growth factor (VEGF), endothelial growth factor (EGF) and insulin-like
growth factors (IGFs). These are slowly released over a period of time, which may extend up to
28 days when PRF is used as the membrane to cover a periodontal defect [3, 6]. The primary
functions of each growth factor are discussed in Table 1.
The most important aspect of PRF is growth factor release, which is why PRFs are being used
as a material to promote healing and regeneration of tissues. Information about the number of
growth factors released over time will aid in understanding the roles played by PRF in tissue
repair. The most comprehensive research in this regard was done by Kobayashi and co-
workers [6]. They evaluated the growth factor release from PRP, L-PRF, and A-PRF over a
period of 10 days and found that L-PRFs and A-PRFs released significantly higher amounts of
growth factors compared to PRPs. PDGF, VEGF, IGF, EGF, and TGF-β1 were evaluated in this
study [6]. The same study showed that A-PRF had significantly more growth factor at 1, 3 or
10 days when compared to L-PRF. This study demonstrated that second-generation PRFs were
superior over first-generation PRP with respect to the number of growth factors released and
A-PRF (low centrifugation concept) can enhance the level of growth factors entrapped in the
fibrin clot.
Growth factor Functions
Platelet-derived growth factors (PDGFs) Specific roles include proliferation of cells, cellular migration and collagen
production for remodeling of extra-cellular matrix to repair the wound.
Transforming growth factor β1 (TGF-β1) Tissue repair, extracellular matrix synthesis and immune modulation.
Specific roles played by TGF-β1 includes angiogenesis, re-epithelization and
regeneration of connective tissue. Due to bone morphogenetic proteins
(BMPs) being part of TGF family. They also play role in bone formation.
Vascular endothelial growth factor (VEGF) Primary function is angiogenesis. Also, plays a role in tissue remodeling.
Endothelial growth factor (EGF) Proliferation and multiplication of endothelial and mesenchymal cells,
which leads to epithelization.
Insulin-like growth factors (IGFs) Cell-protective in nature and participates in proliferation and differentiation
of a variety of cells.
Table 1. Growth factors found in PRF and their functions.
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To understand the roles of PRFs in the wound healing process, it is important to understand
the biological properties of PRFs. It is important to study how the fibrin network releases
growth factors over time leading to enhanced cell migration and proliferation, and thus cell
maturation. The periodontium is a unique complex structure of soft and hard tissues
consisting of gingival connective tissue, periodontal ligament tissue, cementum and bone that
tends to repair and heal by collagenous fibrous tissue reformation and maturation. One of the
important factors responsible for regeneration of the periodontal structures involves periodon-
tal ligament cells. Periodontal ligament cells primarily consist of periodontal ligament fibro-
blasts, which play a key role in the maintenance of periodontal health as they are responsible
for formation and remodeling of alveolar bone in the development of periodontitis [8]. Also,
studies have found that human periodontal ligament fibroblasts (HPLFs) form a heteroge-
neous population, whereas some cells exhibit phenotypic characteristics of osteoblast-like cells
which might have the potential to further differentiate to osteoprogenitor cells leading to
osteoblasts or cementoblasts [8]. Another important cell type which aids in the maintenance
of the periodontal structures along with HPLFs is human gingival fibroblasts (HGFs), which
are abundantly present in the gingival tissue and support the periodontal tissues. It is impor-
tant to understand how PRF biologically affects both HPLF and HGF. Chang and co-workers
[9] investigated the effects of PRF from healthy individuals on HPLF. They measured the
expression of phosphorylated extracellular signal-regulated protein kinase (p-ERK), osteop-
rotegerin (OPG) and alkaline phosphatase (ALP) activity. This study showed that PRF signif-
icantly increased ERK phosphorylation and OPG in HPLF in a time-dependent manner, along
with upregulated ALP activity. This demonstrated that PRF may provide benefits for peri-
odontal tissue regeneration. Another study by Vahabi et al. [10] showed that PRF when
cultured along with HGF for a period of 24, 48 or 72 hours and evaluated through a methyl
thiazol tetrazolium assay led to statistically significant proliferation of HGF at 24 hours, but no
proliferation of HGF was observed at 48 and 72 hours along with the viability of the cells also
decreasing with time. The explanation for proliferation seen up to 24 hours could co-relate
with the maximum number of HGF being reached per available area. More recently, Fujioka-
Kobayashi et al. [11] compared L-PRF and A-PRF with regards to their effects on HGF pro-
liferation and viability. They used the same assay as mentioned in the Vahabi study [10] to
measure proliferation, but additionally, they performed real-time PCR analysis where RNA
was harvested from HGF samples to assess RNA levels of PDGF, TGF-beta, and collagen type I.
This study demonstrated a 200% increase in the proliferation of HGF when combined with
PRF at 24 hours and increased cellular proliferation was noted with increased numbers of cells
at 3 and 5 days. A significant increase in growth factor levels was seen in the culture when
combined with PRF. All of this data supports that PRFs can play a significant role in the
healing and regeneration of periodontal structures when used as biological modifier during
periodontal and oral-maxillofacial surgeries.
2. Applications of PRF: an overview
A true regenerative procedure in periodontology includes regeneration of both soft tissues
(periodontal ligament) and mineralized tissues (cementum and alveolar bone) [12, 13].
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Guided tissue regeneration (GTR) procedures are advocated for regeneration of periodontal
defects and involve the use of barrier membranes which prevents the downgrowth of the
epithelium and excludes gingival connective from the healing wound to allow selective cell
repopulation from the periodontal ligament in alveolar bone. The barrier membranes can be
bioresorbable (made of collagen material) or non-bioresorbable (made of polytetrafluor-
oethylene material) and studies have shown that resorbable membranes show comparable
results with fewer post-surgical complications for GTR procedures when compared to non-
resorbable membranes [12, 14]. Some periodontal regenerative techniques include using
bone replacement grafts like demineralized freeze-dried bone allograft or biological modi-
fiers (i.e. enamel matrix derivative and recombinant human platelet-derived growth factor-
BB) [15–17]. These commercially available growth modifiers have been shown to have sig-
nificant roles in stimulating wound healing and tissue regeneration [12]. PRFs can be used as
a potential barrier membrane with enhanced wound healing properties due to its rich
growth factors content [7]. PRF membranes can be used as an adjunct in the future implant
site preparation [18, 19]. Subepithelial connective tissue grafts (SCTGs) are considered to be
the gold standard for root coverage procedures but involve a second surgical site in the oral
cavity to harvest the graft [20, 21]. The use of PRF for root coverage procedures has been
shown to be an alternative to the SCTG for root coverage procedures with reduced patient
post-surgical discomfort [22, 23].
2.1. Management of extraction sockets with PRF
Following tooth extraction, alveolar bone dimensions are reduced both in vertical and hori-
zontal dimensions as part of the normal healing process [24]. Various treatment interventions
have been carried out to reduce changes in post-extraction alveolar ridge dimensions either for
esthetic purposes or for future implant placement [25]. Treatment options which include use of
allograft or xenograft bone graft materials with or without barrier membranes have shown
positive results in preventing alveolar ridge collapse when compared to sites without any
intervention [25]. Considering the beneficial properties of the PRF, it has been used as an
adjunct in socket grafting procedures with or without bone graft material to improve the
healing and maintenance of the alveolar ridge dimensions [18, 26]. Groups treated with the
PRF showed better results when compared to the non-grafted control groups with respect to
vertical and horizontal dimensions of the alveolar ridge with less discomfort and better clinical
and histological healing pattern in the socket [18, 26, 27]. Figure 3 shows a clinical case of a
patient with a non-restorable molar seeking future implant placement. The tooth was extracted
and the socket was filled with allograft bone particles and covered with a PRF membrane.
Healing at 1 week (Figure 3d) demonstrated enhanced soft tissue healing over the socket with
no reported patient discomfort.
2.2. Guided bone regeneration (GBR) with PRF
Edentulism for long periods or following trauma can cause ridge deficiencies that are not
suitable for implant placement. GBR procedures using barrier membranes and bone grafts
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bone regeneration have shown good clinical outcomes [28, 29] and successful long-term results
with implants placed in the regenerated bone [30]. Based on the defect size and the required
amount of bone to be regenerated, a decision tree is available in the literature which helps the
clinician to decide on the GBR technique [31]. Although GBR procedures for horizontal bone
augmentation have shown predictable results, there are multiple reported complications asso-
ciated with such procedures which can lead to poor or failed treatment outcomes [32]. The
most common wound healing complication reported is membrane exposure which can even-
tually lead to treatment failure or infection [32]. The membrane exposures can happen either
due to the insufficient blood supply to the flaps leading to necrosis or due to the inability of
achieving and maintaining passive primary closure of the flaps [32]. PRF can be used as an
Figure 3. Management of extraction socket and site preparation for future implant placement. (a) Hopeless #30 to be
replaced with dental implant, (b) Atraumatic surgical extraction, (c) allograft bone graft placed in the socket for space
maintenance and covered with PRF membrane, (d) healing at 1 week with visible PRF membrane.
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adjunct in such procedures to enhance healing and regeneration [7, 19, 27]. The patient illus-
trated below (Figure 4) presented with insufficient bone dimensions for implant placement
and underwent a GBR procedure with PRF as an adjunct with resultant good healing without
any reported discomfort.
2.3. PRF used in sinus procedures
The edentulous posterior maxilla can be a challenging site to restore with implants due to
alveolar ridge resorption and the presence of maxillary sinus pneumatization which tends to
increase over time. Sinus augmentation procedures are the treatment of choice to restore
Figure 4. GBR at site #9 for future implant placement. (a) #9 Edentulous site with insufficient bone for implant placement,
(b) incisions, (c) defect with decortications, (d) particulate bone allograft to fill the defect, (e) PRF membrane placed
horizontally over the bone graft. (f) Second PRF membrane placed vertically, (g) titanium-reinforced d-PTFE membrane
for space maintenance placed over the PRF membrane, (h) primary closure achieved, (i) healing at 1 week, (j) healing at 4-
months after titanium-reinforced d-PTFE membrane removal.
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posterior maxilla with deficient bone height due to sinus pneumatization [33]. The two most
common sinus augmentation procedures include the osteotome sinus augmentation and lat-
eral window sinus augmentation with a common goal of increasing vertical bone dimensions.
Both the procedures have shown high long-term implant survival rates following sinus aug-
mentation [33]. Due to the healing and regenerative properties of PRF, it has been incorporated
into sinus procedures: as a sole grafting material, in combination with allograft and xenograft
material, as a membrane to cover the graft material, and to repair intra-operative Schneiderian
membrane perforations [34–36]. PRF when used either as a sole grafting material or in combi-
nation with other materials have shown positive and promising results with respect to faster
healing and maturation of bone [35]. The case demonstrated below (Figure 5) shows the use of
Figure 5. Lateral window sinus augmentation procedure to place implants at #3 and 4, due to insufficient vertical height.
(a) Full thickness mucoperiosteal flap reflection, (b) surgical guide at place to guide lateral window position, (c) lateral
window ostectomy created, (d) sinus elevator used to elevate Schneiderian membrane, (e) intact Schneiderian membrane,
(f) accidental Schneiderian membrane perforation, (g) Schneiderian membrane perforation, (h) PRF membrane used to
repair Schneiderian membrane, (i) second PRF membrane to provide stability and maintaining integrity of the perforated
Schneiderian membrane, (j) Schneiderian membrane repaired, (k) primary closure achieved, (l) healing at 2-weeks.
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PRF to reconstruct a Schneiderian membrane perforation, the most common intra-operative
complication of the lateral window sinus augmentation technique [37].
2.4. Root coverage procedure with PRF
Another aspect of the periodontal therapy is the treatment of mucogingival defects which refers
to gingival recession leading to root exposure. Gingival recession and root exposure can lead to
sensitivity and esthetic concerns for the patient. A systematic review has shown predictable
results with root coverage procedures for Miller Class I and Class II defects [21]. The most
predictable results have been shown when SCTG is used as a material for root coverage proce-
dure along with the coronal advancement of the flaps [21]. For harvesting connective tissue graft,
a second surgical site (i.e. palate or tuberosity region) is needed in the oral cavity which leads to
increased patient discomfort. Clinical studies have shown similar results to SCTG when PRF is
used as a material for root coverage procedures [22, 23]. Figure 6 shows a successful root
Figure 6. Root coverage procedure for #7–11. (a) Gingival recession shown from #7–11, (b, c) tunnel preparation shown
for PRF placement, (d) Exudate collected after fibrin clot compression used to irrigate the site, (e) PRF membrane shown
over the site, (f) PRF membrane placed in the tunnel, (g) soft tissue is coronally advanced with the help of sutures, (h)
healing at 2 weeks, (i) stable root coverage at 3 months.
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coverage procedure when PRF is tunneled and flap is coronally advanced. Healing and root
coverage is stable at 3 months (Figure 6i).
3. Future scope and conclusion
The current research on PRF focuses on the clinical applications of the PRF in periodontology
and implant dentistry and has shown promising results with better healing outcomes and less
patient discomfort. At the same time, there is need to evaluate the properties of PRF which
includes quantification of growth factors and the number of growth factors released from PRF
over time. It is important to study the variables including age, sex, and the influence of any
systemic disease on PRF quality. Further research is also needed on different formulation of the
platelet concentrates to make it optimize its use for different procedures.
Overall, PRF can be utilized for many periodontal and implant procedures capitalizing on
taking advantage of considering (1) the use of an autologous source, (2) enhanced healing and
regeneration potential, and (3) a less expensive alternative to other commercially available
biological modifiers.
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